Jean Bizzari
Director/Board Member at ADC THERAPEUTICS SA
Net worth: 2 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bernd Seizinger | M | 67 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | 9 years |
| Thomas Bures | M | 49 | 7 years | |
| Jeffrey Henderson | M | 59 | 9 years | |
| Marc Buyse | M | - |
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | 36 years |
| Ameet Mallik | M | 51 | 2 years | |
| Oren Gilad | M | 56 | 2 years | |
| Christian Rohlff | M | 62 |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | 21 years |
| Richard Peters | M | 61 | 4 years | |
| Mark Snyder | M | 57 | 2 years | |
| James Geraghty | M | 69 | 7 years | |
| John Hamill | M | 60 | 1 years | |
| Damien Tremolet | M | - |
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | - |
| Viviane Monges | F | 60 | 3 years | |
| Akiko Miyashita | F | 68 | 2 years | |
| Thomas Pfisterer | M | 42 | 8 years | |
| Henri Tassenoy | M | - |
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | - |
| Marc Duey | M | 68 | 2 years | |
| Michael Grissinger | M | 70 | 2 years | |
| Barbara Duncan | F | 59 | 1 years | |
| Bernadette Connaughton | F | 65 | 6 years | |
| Ann J. Barbier | M | 59 | 6 years | |
| Tyrell J. Rivers | M | 51 | 6 years | |
| Victor Sandor | M | 57 | 4 years | |
| Eran Ben-Dor | M | - | 5 years | |
| Peter Kiener | M | 72 | 6 years | |
| John Henneman | M | 62 | 5 years | |
| Rifat Pamukcu | M | 66 | 2 years | |
| Christopher Kiritsy | M | 59 | 8 years | |
| Matthew Sherman | M | 68 | 6 years | |
| Tram Bui | F | - | 2 years | |
| Peter Hug | M | 65 | 5 years | |
| Gabriela Gruia | M | 67 | 1 years | |
| Agnès Bernet | M | - |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | 16 years |
| Patrick Mehlen | M | - |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | 16 years |
| Yvonne Naughton | M | - | 3 years | |
| Mathias Hukkelhoven | M | 70 | 2 years | |
| Maya Said | M | 47 | 5 years | |
| Kayti Aviano | F | - | 7 years | |
| Linda Danielson | F | - |
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | 18 years |
| Steve Knowles | M | - | 6 years | |
| Kimberly Pope | F | 57 | 4 years | |
| Hitto Kaufmann | M | 53 | 5 years | |
| Amy Marinne Fox | F | - | 4 years | |
| Patrick van Berkel | M | 55 | 12 years | |
| Marc Melviez | M | - |
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | - |
| Alain Herrera | M | 74 |
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | - |
| Christophe Guichard | M | 55 |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | 11 years |
| Diego du Monceau de Bergendal | M | 75 |
European Organisation for Research & Treatment of Cancer
| - |
| Zeev Weiss | M | 62 | 2 years | |
| Jason Gould | M | 55 |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | - |
| Ron Squarer | M | 57 | 4 years | |
| Victoria Billecocq | F | - |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | 3 years |
Connections Chart
Multi-company connection
Former connections
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 69 | 69.00% |
| Switzerland | 15 | 15.00% |
| Belgium | 7 | 7.00% |
| Israel | 5 | 5.00% |
| France | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jean Bizzari
- Personal Network